Mersana Therapeutics Inc. (MRSN) is priced at $18.60 after the most recent trading session. At the very opening of the session, the stock price was $17.92 and reached a high price of $18.79, prior to closing the session it reached the value of $17.89. The stock touched a low price of $17.85.
Recently in News on October 14, 2020, Mersana Therapeutics to Present Preclinical Data from Immunosynthen STING-Agonist ADC Platform at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting. Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will present preclinical data from its novel Immunosynthen STING-agonist ADC platform at the 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) taking place virtually from November 9-14, 2020. You can read further details here
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
Mersana Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $26.64 on 09/16/20, with the lowest value was $4.12 for the same time period, recorded on 03/20/20.
Mersana Therapeutics Inc. (MRSN) full year performance was 894.65%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Mersana Therapeutics Inc. shares are logging -30.18% during the 52-week period from high price, and 1309.09% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.32 and $26.64.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1605756 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Mersana Therapeutics Inc. (MRSN) recorded performance in the market was 224.61%, having the revenues showcasing -9.53% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.31B, as it employees total of 83 workers.
Analysts verdict on Mersana Therapeutics Inc. (MRSN)
During the last month, 5 analysts gave the Mersana Therapeutics Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 20.09, with a change in the price was noted -3.14. In a similar fashion, Mersana Therapeutics Inc. posted a movement of -14.44% for the period of last 100 days, recording 964,030 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for MRSN is recording 0.02 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.
Mersana Therapeutics Inc. (MRSN): Technical Analysis
Raw Stochastic average of Mersana Therapeutics Inc. in the period of last 50 days is set at 28.21%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 61.01%. In the last 20 days, the company’s Stochastic %K was 39.10% and its Stochastic %D was recorded 23.99%.
Let’s take a glance in the erstwhile performances of Mersana Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 224.61%. Additionally, trading for the stock in the period of the last six months notably improved by 105.52%, alongside a boost of 894.65% for the period of the last 12 months. The shares increased approximately by 0.98% in the 7-day charts and went up by -2.00% in the period of the last 30 days. Common stock shares were lifted by -9.53% during last recorded quarter.